Literature DB >> 17318570

Preoperative B-scan ultrasonography of the vitreoretinal interface in phakic patients undergoing rhegmatogenous retinal detachment repair and its prognostic significance.

Flávio A Rezende1, Michael A Kapusta, Miguel N Burnier, Rogério A Costa, Ingrid U Scott.   

Abstract

PURPOSE: To perform ultrasonographic evaluation of the preoperative status of the posterior vitreoretinal interface in phakic patients undergoing surgery for retinal detachment (RD) with flap tear(s) and to investigate its relationship with postoperative anatomic and visual acuity outcomes.
METHODS: A prospective, consecutive case series including 50 phakic eyes of 49 patients with retinal detachment and flap tear(s) undergoing retinal detachment surgery by a single vitreoretinal surgeon, who was unaware of the patient's preoperative B-scan ultrasonographic findings. Main outcome measures were comparisons between patients with partial versus complete posterior vitreous detachment (PVD) of primary retinal reattachment rates (retinal reattachment with a single surgical procedure), rates of retinal reattachment at month 12, and visual acuity outcomes at month 12.
RESULTS: Partial PVD was observed in 22 (44%) eyes and complete PVD in 28 (56%) eyes. Eighteen eyes underwent pneumatic retinopexy, 15 underwent scleral buckling, and 17 underwent pars plana vitrectomy. Retinal reattachment with a single surgical procedure was achieved in 76% (38/50) of eyes, including 54.5% (12/22) of eyes with partial PVD at baseline and 92.9% (26/28) of eyes with complete PVD at baseline (P < 0.01). Stratification by type of surgical intervention demonstrated a significantly higher rate of primary anatomic success for pneumatic retinopexy among patients with complete PVD compared to partial PVD (P = 0.02). Retinal reattachment at month 12 was achieved in 100% (50/50) of eyes. At last follow-up, the mean (+/-SD) number of interventions was 1.70 (+/-1.10) for patients with partial PVD at baseline and 1.10 (+/-0.30) for patients with complete PVD (P < 0.01). There was no significant difference among the groups in mean change in visual acuity from baseline to month 12, nor in the distribution of visual acuities at month 12.
CONCLUSIONS: In phakic patients with retinal detachment and flap tear(s), a higher primary anatomic success rate may be associated with the presence of a complete PVD compared to a partial PVD. Subgroup analysis suggests that the presence of partial PVD at baseline might influence negatively the primary anatomic success rate, particularly for eyes undergoing pneumatic retinopexy.

Entities:  

Mesh:

Year:  2007        PMID: 17318570     DOI: 10.1007/s00417-007-0541-5

Source DB:  PubMed          Journal:  Graefes Arch Clin Exp Ophthalmol        ISSN: 0721-832X            Impact factor:   3.117


  16 in total

1.  [Relationship between the prognosis of retinal detachment in emmetropic eyes and vitreous changes].

Authors:  X Sun; X Zhang; L Huang
Journal:  Zhonghua Yan Ke Za Zhi       Date:  1999-11

2.  Pneumatic retinopexy. A multicenter randomized controlled clinical trial comparing pneumatic retinopexy with scleral buckling. The Retinal Detachment Study Group.

Authors:  P E Tornambe; G F Hilton
Journal:  Ophthalmology       Date:  1989-06       Impact factor: 12.079

3.  Anatomic outcome of scleral buckling surgery in primary rhegmatogenous retinal detachment.

Authors:  F Afrashi; C Akkin; S Egrilmez; T Erakgun; J Mentes
Journal:  Int Ophthalmol       Date:  2006-09-07       Impact factor: 2.031

Review 4.  Vitreous base classification of retinal tears: clinical application.

Authors:  J Sigelman
Journal:  Surv Ophthalmol       Date:  1980 Sep-Oct       Impact factor: 6.048

5.  Comparative study of vitreoretinal relationships using biomicroscopy and ultrasound.

Authors:  C W Arzabe; J Akiba; A E Jalkh; M A Quiroz; C L Trempe; J W McMeel; J M Celorio
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1991       Impact factor: 3.117

6.  Pneumatic retinopexy: the evolution of case selection and surgical technique. A twelve-year study of 302 eyes.

Authors:  P E Tornambe
Journal:  Trans Am Ophthalmol Soc       Date:  1997

7.  Treatment of retinal tears and lattice degenerations in fellow eyes in high risk patients suffering retinal detachment: a prospective study.

Authors:  L Mastropasqua; P Carpineto; M Ciancaglini; G Falconio; P E Gallenga
Journal:  Br J Ophthalmol       Date:  1999-09       Impact factor: 4.638

8.  Residual vitreous cortex after surgical posterior vitreous separation visualized by intravitreous triamcinolone acetonide.

Authors:  Koh-Hei Sonoda; Taiji Sakamoto; Hiroshi Enaida; Miho Miyazaki; Yoshihiro Noda; Takao Nakamura; Akifumi Ueno; Mitsunobu Yokoyama; Toshiaki Kubota; Tatsuro Ishibashi
Journal:  Ophthalmology       Date:  2004-02       Impact factor: 12.079

9.  Comparative study of incomplete posterior vitreous detachment as a risk factor for proliferative vitreoretinopathy.

Authors:  C Capeans; J Lorenzo; L Santos; A Suarez; M J Copena; M J Blanco; M Sánchez-Salorio
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1998-07       Impact factor: 3.117

10.  Phakic retinal detachments in the elderly.

Authors:  C P Wilkinson
Journal:  Retina       Date:  1995       Impact factor: 4.256

View more
  3 in total

1.  Intravitreal injection of 0.3 ml of SF6 gas for persistent subfoveal fluid after scleral buckling for rhegmatogenous retinal detachment.

Authors:  Hirotaka Itakura; Shoji Kishi
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-04-25       Impact factor: 3.117

2.  Accuracy of Spectral-Domain OCT of the Macula for Detection of Complete Posterior Vitreous Detachment.

Authors:  Eileen S Hwang; Jessica A Kraker; Kim J Griffin; J Sebag; David V Weinberg; Judy E Kim
Journal:  Ophthalmol Retina       Date:  2019-11-02

3.  Outcomes of surgical repair of Retinoschisis-associated retinal detachment compared to Rhegmatogenous retinal detachment.

Authors:  Jérôme Garneau; Mélanie Hébert; Eunice You; Alexandre Lachance; Serge Bourgault; Mathieu Caissie; Éric Tourville; Ali Dirani
Journal:  BMC Ophthalmol       Date:  2022-01-04       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.